FDA Inspection 1149817 — Banco Vida Corp.

Banco Vida Corp. — FEI 3011849882

The FDA completed an inspection of Banco Vida Corp. on Aug 12, 2021 in San Juan, PR. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 1 citation was issued during this inspection. Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Aug 12, 2021
Fiscal Year
2021
Product Type
Biologics
Project Area
Blood and Blood Products
Location
San Juan, PR (United States)

Citations

IDCFRDescription
1221321 CFR 1271.47(a)Testing, screening, donor eligibility procedures

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.